TGHSA
AMRX icon

TPG Group Holdings (SBS) Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

TPG Group Holdings (SBS) Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$86.6M Hold
16,213,367
– – 0.86% 25
2021
Q2 		$83M Hold
16,213,367
– – 0.59% 26
2021
Q1 		$109M Hold
16,213,367
– – 1.27% 19
2020
Q4 		$74.1M Hold
16,213,367
– – 0.82% 26
2020
Q3 		$62.9M Hold
16,213,367
– – 1.13% 21
2020
Q2 		$77.2M Hold
16,213,367
– – 1.36% 17
2020
Q1 		$56.4M Hold
16,213,367
– – 1.3% 19
2019
Q4 		$78.1M Hold
16,213,367
– – 1.15% 19
2019
Q3 		$47M Buy
16,213,367
+12,328,767
+317% +$43M 0.69% 30
2019
Q2 		$27.9M Hold
3,884,600
– – 0.42% 32
2019
Q1 		$55M Hold
3,884,600
– – 1.08% 23
2018
Q4 		$52.6M Hold
3,884,600
– – 0.85% 24
2018
Q3 		$86.2M Sell
3,884,600
-224,989
-5% -$4.73M 1.1% 19
2018
Q2 		$67.4M Buy
+4,109,589
New +$72.1M 0.88% 23

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors's AMRX Position: Q3 2021 in Review

TPG Group Holdings (SBS) Advisors held its Amneal Pharmaceuticals (AMRX) position steady in Q3 2021 at 16,213,367 shares worth $86.6M. The position accounts for 0.86% of the portfolio, ranked #25.

TPG Group Holdings (SBS) Advisors first reported a position in AMRX in Q2 2018 and has held it in 14 quarters since. The position peaked at $109M in Q1 2021. 154 funds tracked by Wall St. Rank hold AMRX as of Q3 2021.

  • TPG Group Holdings (SBS) Advisors held 16,213,367 shares of Amneal Pharmaceuticals worth $86.6M as of Q3 2021.
  • TPG Group Holdings (SBS) Advisors left its Amneal Pharmaceuticals share count unchanged in Q3 2021.
  • Amneal Pharmaceuticals made up 0.86% of TPG Group Holdings (SBS) Advisors's portfolio in Q3 2021, its #25 holding.
  • TPG Group Holdings (SBS) Advisors first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 14 quarters since.
  • TPG Group Holdings (SBS) Advisors's Amneal Pharmaceuticals position peaked at $109M in Q1 2021.
  • 154 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2021.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.